|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/22/24 Bioxytran, Inc. 10-K 12/31/23 74:7.4M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.86M
2: EX-10.81 Material Contract HTML 60K
3: EX-10.82 Material Contract HTML 38K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
6: EX-32 Certification -- §906 - SOA'02 HTML 23K
12: R1 Cover HTML 90K
13: R2 Consolidated Balance Sheets HTML 119K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 41K
15: R4 Consolidated Statements of Operations HTML 102K
16: R5 Consolidated Statement of Changes in Stockholders' HTML 104K
Deficit
17: R6 Consolidated Statement of Cash Flows HTML 96K
18: R7 Background and Organization HTML 46K
19: R8 Summary of Significant Accounting Policies HTML 50K
20: R9 Going Concern and Management's Liquidity Plans HTML 28K
21: R10 Related Party Transactions HTML 28K
22: R11 Intangibles HTML 33K
23: R12 Accounts Payables and Accrued Expenses and Other HTML 47K
Current Liabilities
24: R13 Convertible Notes Payable HTML 73K
25: R14 Stockholders? Equity HTML 139K
26: R15 Stock Option Plan and Stock-Based Compensation HTML 188K
27: R16 Non-Controlling Interest HTML 45K
28: R17 Provision for Income Taxes HTML 49K
29: R18 Commitments and Contingencies HTML 30K
30: R19 Subsequent Events HTML 48K
31: R20 Summary of Significant Accounting Policies HTML 76K
(Policies)
32: R21 Intangibles (Tables) HTML 31K
33: R22 Accounts Payables and Accrued Expenses and Other HTML 45K
Current Liabilities (Tables)
34: R23 Convertible Notes Payable (Tables) HTML 62K
35: R24 Stockholders? Equity (Tables) HTML 93K
36: R25 Stock Option Plan and Stock-Based Compensation HTML 136K
(Tables)
37: R26 Non-Controlling Interest (Tables) HTML 35K
38: R27 Provision for Income Taxes (Tables) HTML 38K
39: R28 Background and Organization (Details Narrative) HTML 74K
40: R29 Summary of Significant Accounting Policies HTML 48K
(Details Narrative)
41: R30 Going Concern and Management's Liquidity Plans HTML 34K
(Details Narrative)
42: R31 Related Party Transactions (Details Narrative) HTML 27K
43: R32 Schedule of Intangibles (Details) HTML 29K
44: R33 Intangibles (Details Narrative) HTML 23K
45: R34 Schedule of Accounts Payables and Accrued Expenses HTML 59K
and Other Current Liabilities (Details)
46: R35 Schedule of Accounts Payables and Accrued Expenses HTML 41K
and Other Current Liabilities (Details)
(Parenthetical)
47: R36 Accounts Payables and Accrued Expenses and Other HTML 27K
Current Liabilities (Details Narrative)
48: R37 Schedule of Outstanding Convertible Notes HTML 41K
(Details)
49: R38 Schedule of Outstanding Convertible Notes HTML 41K
(Details) (Parenthetical)
50: R39 Schedule of Convertible Conversion of Accrued HTML 35K
Interest and Principal (Details)
51: R40 Schedule of Convertible Conversion of Accrued HTML 35K
Interest and Principal (Details) (Parenthetical)
52: R41 Convertible Notes Payable (Details Narrative) HTML 66K
53: R42 Schedule of Stock Warrants Valuation Assumptions HTML 38K
(Details)
54: R43 Schedule of Warrant Activity (Details) HTML 49K
55: R44 Schedule of Warrant Activity (Details) HTML 30K
(Parenthetical)
56: R45 Schedule of Warrant Outstanding and Exercisable HTML 44K
Warrants (Details)
57: R46 Schedule of Non-Vested Warrants (Details) HTML 41K
58: R47 Stockholders? Equity (Details Narrative) HTML 150K
59: R48 Schedule of Fair Market Value (Details) HTML 50K
60: R49 Schedule of Stock Options Activity (Details) HTML 62K
61: R50 Schedule of Stock Option Vested (Details) HTML 67K
62: R51 Stock Option Plan and Stock-Based Compensation HTML 152K
(Details Narrative)
63: R52 Schedule of Non Controlling Interest (Details) HTML 38K
64: R53 Non-Controlling Interest (Details Narrative) HTML 53K
65: R54 Schedule of Deferred Tax Assets (Details) HTML 29K
66: R55 Schedule of Effective Tax Rate (Details) HTML 23K
67: R56 Provision for Income Taxes (Details Narrative) HTML 41K
68: R57 Commitments and Contingencies (Details Narrative) HTML 24K
69: R58 Subsequent Events (Details Narrative) HTML 105K
71: XML IDEA XML File -- Filing Summary XML 129K
74: XML XBRL Instance -- form10-k_htm XML 1.55M
70: EXCEL IDEA Workbook of Financial Report Info XLSX 138K
8: EX-101.CAL Inline XBRL Taxonomy Extension Calculation XML 137K
Linkbase Document -- bixt-20231231_cal
9: EX-101.DEF Inline XBRL Taxonomy Extension Definition Linkbase XML 648K
Document -- bixt-20231231_def
10: EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase XML 1.01M
Document -- bixt-20231231_lab
11: EX-101.PRE Inline XBRL Taxonomy Extension Presentation XML 853K
Linkbase Document -- bixt-20231231_pre
7: EX-101.SCH Inline XBRL Taxonomy Extension Schema Document -- XSD 160K
bixt-20231231
72: JSON XBRL Instance as JSON Data -- MetaLinks 374± 554K
73: ZIP XBRL Zipped Folder -- 0001493152-24-011014-xbrl Zip 342K
Exhibit 31.2
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14
I, Ola Soderquist, certify that:
| 1. | We have reviewed this Annual Report on Form 10-K of BIOXYTRAN, Inc; | |
| 2. | Based on our knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
| 3. | Based on our knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
| 4. | The registrant’s other certifying officer and we are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | We have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
| a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| BIOXYTRAN, INC. | ||
| Date: March 22, 2024 | By: | /s/ Ola Soderquist |
| Ola Soderquist | ||
| Chief Financial Officer | ||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/22/24 | |||
| For Period end: | 12/31/23 | 5 | ||
| List all Filings | ||||